Date: 2025/01/30 - 15:32
Poor oral health could be a potential risk factor for cardiovascular disease. New research shows that good oral health habits, such as flossing, may reduce the risk of stroke and atrial fibrillation (AFib).
Date: 2025/01/22 - 00:32
A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different health outcomes. The findings show benefits for brain and heart health, but risks of developing gastrointestinal, kidney, and pancreatic issues.
Date: 2025/01/21 - 20:31
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, addiction, heart disease, and gastrointestinal problems, among others.
Date: 2024/11/03 - 18:50
What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can still help people lose weight with fewer side effects at a lower cost.